Cite
HARVARD Citation
Pragosa, A. et al. (n.d.). PS-014 Safety analysis of ledipasvir/sofosbuvir, with or without ribavirin, in patients with chronic hepatitis C virus infection: Adverse events and drug interactions. European journal of hospital pharmacy. p. A220. [Online].